Targeting Post-translational Modifications on Tau as a Therapeutic Strategy for Alzheimer's Disease
Year: 2011
Type: review
Source: Journal of Neurogenetics
Authors: Jacob Newman Marcus, Joel Schachter
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2023241993
